In tumors, DNA from dying cancer cells can gain access to the cytosol of antigen-presenting cells and activate the cGAS-STING pathway, leading to induction of type I interferons and other immune stimulatory molecules, which promote antitumor immunity through activation of T cells and natural killer (NK) cells (12, 13). This evidence concerns the gene STING1 and cancer.